Precision Medicine for NASH and NAFLD

Join us to learn more about the creation of the worlds first data commons for Non Alcoholic Fatty Liver Disease (NAFLD). SteatoSITE is an integrated gene to patient data commons for NAFLD research. The event will detailed insight to the building, delivery and results of the project, covering topics such as design, key results, possible uses and collaborations, key lessons learnt and wider data management considerations as we move forward with patient data and digital progression of health outcomes. Meet Precision Medicine Scotland and understand how we can work with you to further your research and commercialization goals in the Precision Medicine arena.